233 related articles for article (PubMed ID: 24954580)
1. Statins in neurological disorders: an overview and update.
Malfitano AM; Marasco G; Proto MC; Laezza C; Gazzerro P; Bifulco M
Pharmacol Res; 2014 Oct; 88():74-83. PubMed ID: 24954580
[TBL] [Abstract][Full Text] [Related]
2. Potential therapeutic role of statins in neurological disorders.
Bifulco M; Malfitano AM; Marasco G
Expert Rev Neurother; 2008 May; 8(5):827-37. PubMed ID: 18457539
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic potential of statins in neurological disorders.
Rajanikant GK; Zemke D; Kassab M; Majid A
Curr Med Chem; 2007; 14(1):103-12. PubMed ID: 17266571
[TBL] [Abstract][Full Text] [Related]
4. Statins: multiple neuroprotective mechanisms in neurodegenerative diseases.
Wang Q; Yan J; Chen X; Li J; Yang Y; Weng J; Deng C; Yenari MA
Exp Neurol; 2011 Jul; 230(1):27-34. PubMed ID: 20406638
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of HMG-CoA reductase inhibitors in the processes of neurodegeneration.
Saeedi Saravi SS; Saeedi Saravi SS; Arefidoust A; Dehpour AR
Metab Brain Dis; 2017 Aug; 32(4):949-965. PubMed ID: 28578514
[TBL] [Abstract][Full Text] [Related]
6. Use of statins in CNS disorders.
Cucchiara B; Kasner SE
J Neurol Sci; 2001 Jun; 187(1-2):81-9. PubMed ID: 11440749
[TBL] [Abstract][Full Text] [Related]
7. Statins: multiple mechanisms of action in the ischemic brain.
Cimino M; Gelosa P; Gianella A; Nobili E; Tremoli E; Sironi L
Neuroscientist; 2007 Jun; 13(3):208-13. PubMed ID: 17519364
[TBL] [Abstract][Full Text] [Related]
8. Role of HMG-CoA reductase inhibitors in neurological disorders : progress to date.
Reiss AB; Wirkowski E
Drugs; 2007; 67(15):2111-20. PubMed ID: 17927279
[TBL] [Abstract][Full Text] [Related]
9. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
Farooqui AA; Ong WY; Horrocks LA; Chen P; Farooqui T
Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective properties of statins.
Stepień K; Tomaszewski M; Czuczwar SJ
Pharmacol Rep; 2005; 57(5):561-9. PubMed ID: 16227638
[TBL] [Abstract][Full Text] [Related]
11. Statins as potential therapeutic agents in neuroinflammatory disorders.
Stüve O; Youssef S; Steinman L; Zamvil SS
Curr Opin Neurol; 2003 Jun; 16(3):393-401. PubMed ID: 12858078
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders.
Kosowski M; Smolarczyk-Kosowska J; Hachuła M; Maligłówka M; Basiak M; Machnik G; Pudlo R; Okopień B
Molecules; 2021 May; 26(10):. PubMed ID: 34064670
[TBL] [Abstract][Full Text] [Related]
13. Statins: mechanisms of neuroprotection.
van der Most PJ; Dolga AM; Nijholt IM; Luiten PG; Eisel UL
Prog Neurobiol; 2009 May; 88(1):64-75. PubMed ID: 19428962
[TBL] [Abstract][Full Text] [Related]
14. Statins in nervous system-associated diseases: angels or devils?
Lei Q; Peng WN; You H; Hu ZP; Lu W
Pharmazie; 2014 Jun; 69(6):448-54. PubMed ID: 24974580
[TBL] [Abstract][Full Text] [Related]
15. The complex actions of statins in brain and their relevance for Alzheimer's disease treatment: an analytical review.
Mendoza-Oliva A; Zepeda A; Arias C
Curr Alzheimer Res; 2014; 11(9):817-33. PubMed ID: 25274112
[TBL] [Abstract][Full Text] [Related]
16. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
Vaughan CJ; Delanty N; Basson CT
CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031
[TBL] [Abstract][Full Text] [Related]
17. Statins in neurological disorders: mechanisms and therapeutic value.
Reiss AB; Wirkowski E
ScientificWorldJournal; 2009 Nov; 9():1242-59. PubMed ID: 19882094
[TBL] [Abstract][Full Text] [Related]
18. Statins--a cure-all for the brain?
Menge T; Hartung HP; Stüve O
Nat Rev Neurosci; 2005 Apr; 6(4):325-31. PubMed ID: 15803163
[TBL] [Abstract][Full Text] [Related]
19. [Statins and stroke].
Chudzik W; Kaczorowska B; Chmielewski H; Przybyła M; Gałka M
Pol Merkur Lekarski; 2005 Oct; 19(112):591-5. PubMed ID: 16379334
[TBL] [Abstract][Full Text] [Related]
20. Is targeting eNOS a key mechanistic insight of cardiovascular defensive potentials of statins?
Balakumar P; Kathuria S; Taneja G; Kalra S; Mahadevan N
J Mol Cell Cardiol; 2012 Jan; 52(1):83-92. PubMed ID: 21968328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
